WHO ICTRP trial
The prospective clinical study of zoledronic acid in the prevention of…
ChiCTR2000031553 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000031553 |
|---|---|
| Public title | The prospective clinical study of zoledronic acid in the prevention of steroid-related bone disease after chemotherapy in acute lymphoblastic leukemia |
| Scientific title | The prospective clinical study of zoledronic acid in the prevention of steroid-related bone disease after chemotherapy in acute lymphoblastic leukemia |
| Primary sponsor | Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Acute lymphoblastic leukemia |
| Interventions | preventive intervention:Zoledronic acid combined with calcium , vitamin D;therapeutic intervention:Zoledronic acid combined with calcium , vitamin D |
| Registration date | Apr 4, 2020 |
| Target size | preventive intervention:103;therapeutic intervention:103 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: